Company / Current Liabilities per Share
Charles River Laboratories Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$22.76
FY2025
5-year range
$19.36 / $22.76
FY2021-FY2025
Trend
+17.6%
vs FY2024
Sector context
#25 of 159
Health Care
What the data says
Charles River Laboratories's current liabilities per share of $22.76 is higher than 84% of companies in the Health Care sector (FY2025). Current Liabilities per Share returned to growth in FY2025 after 2 years of decline, reaching $22.76.
Based on SEC 10-K filings.
22.76 in FY2025 with a 5-year CAGR of +5.8%. Top quartile in the Health Care sector.
Increased from $20.71 to $22.76 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +1.7%
- 5-Year CAGR
- +5.8%
- 10-Year CAGR
- -
Sector benchmark
-23.8% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 17.6% year-over-year.
- Ranks #25 out of 159 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.76 | +17.6% |
| FY2024 | $19.36 | -6.5% |
| FY2023 | $20.71 | -4.2% |
| FY2022 | $21.62 | +4.2% |
| FY2021 | $20.76 | +21.0% |
| FY2020 | $17.16 | +16.5% |
| FY2019 | $14.73 | +25.1% |
| FY2018 | $11.78 | +20.3% |
| FY2017 | $9.79 | +6.4% |
| FY2016 | $9.20 | +39.7% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026